Michael Baker has joined the board of BONESUPPORT, a medical device company in Lund, Sweden that develops CERAMENT™ for the treatment of osteoporotic fractures. BONESUPPORT has subsidiaries in the United States, the Netherlands and Germany.
"I am looking forward to working for BONESUPPORT", says Mr. Baker. "The company is in an exciting phase of commercialization and establishment in the global market and offers a platform technology with great commercial potential."
Mr. Baker is currently President and CEO of Pulmonx, a rapidly growing developer of minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. He has held executive positions in the U.S. and European medical device industries for more than 20 years. Much of his career has been devoted to developing and commercializing new devices, as well as helping small businesses grow and establish themselves in the market.
As President and CEO for 11 years, Mr. Baker led ArthroCare Corporation’s transition from a development company to a large international orthopedics group. He also held executive positions at Medtronic in both the United States and Europe for eight years.
"Having Michael on our board means a lot to us," says Fredrik Lindberg, President and CEO of BONESUPPORT in Lund. "He possesses not only enormous knowledge of the industry, but the unique experience of having successfully built companies for the global orthopedics and spinal surgery market."
Among the many boards on which Mr. Baker has served are ArthroCare Corporation, Conceptus Inc., ProDuct Health and Synectics Medical AB. He holds a B.S. from West Point and an M.B.A. from the University of Chicago.
For additional information, feel free to call:
Fredrik Lindberg, President and CEO
Phone: +46 708 86 53 70
Press photos are available at www.bonesupport.com
BONESUPPORT
BONESUPPORT AB is an innovative Swedish medical technology company that specializes in the development of high-tech solutions for the treatment of osteoporotic fractures, e.g. vertebral compression fractures. Founded in 1999, the company has over 30 employees and is headquarted at Ideon Science Park in Lund, Sweden. BONESUPPORT has subsidiaries in the United States, Netherlands and Germany. Its two main trademarks are CERAMENT™ and ULTRAZONIX®.